Dermatitis, Atopic: all 1,444 studies
Page 14 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.
- Atopic Dermatitis Biomarker Identification Trial in Omalizumab UsageCompletedNCT01179529Phase 2
- Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.CompletedNCT01177566Phase 4
- Evaluation of A-1 Cool Cream Efficacy for Treatment Atopic DermatitisStatus unknownNCT01174511Phase 1/2
- Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and ImmunityCompletedNCT01148667Phase 4
- Health Literacy for Children With Atopic Dermatitis and Their CaregiversTerminatedNCT01138761Not applicable
- Pimecrolimus and Epidermal Barrier FunctionCompletedNCT01132079Not applicable
- Efficacy and Safety of the Association Drugs in Patients With Allergic DermatitisWithdrawnNCT01125761Phase 3
- A Pilot Study of Lactofiltrum to Treat Atopic Dermatitis in AdultsCompletedNCT01124318Phase 2/3
- A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic DermatitisTerminatedNCT01122914Phase 1
- Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic EczemaCompletedNCT01119313Phase 2
- Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 CreamCompletedNCT01098734Phase 2
- Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT01079897Not applicable
- Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisCompletedNCT01077882Phase 4
- Knowledge Base in the Treatment of Atopic Dermatitis Among Thai PediatriciansCompletedNCT01069666
- Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids ApplicationCompletedNCT01063218Phase 4
- the Effectiveness of Probiotics on Atopic Dermatitis With Cow Milk AllergyWithdrawnNCT01045486Not applicable
- Safety and Efficacy of DNK333 in Atopic Dermatitis PatientsCompletedNCT01033097Phase 2
- Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive DermatosisStatus unknownNCT01011621Phase 3
- Probiotic Bacteria to Infants With Atopic DermatitisCompletedNCT01007331Not applicable
- A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic DermatitisCompletedNCT01005823Phase 1
- CT 327 in the Treatment of Atopic DermatitisTerminatedNCT00996008Phase 2
- The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of PhotodamageCompletedNCT00991198Phase 2
- Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic DermatitisCompletedNCT00985894Not applicable
- Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic DermatitisCompletedNCT00980629Phase 2
- Sinecort Pilot Efficacy StudyCompletedNCT00980135Phase 2
- Dose Escalation of Different Concentrations of ZK 245186 in Atopic DermatitisCompletedNCT00944632Phase 2
- A Study to Determine the Safety, Tolerability and Efficacy of KP-413 in Subjects With Atopic Dermatitis(AD)CompletedNCT00932074Phase 1/2
- Topical Application of AS101 for the Treatment of Atopic DermatitisTerminatedNCT00927212Phase 2
- Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under OcclusionCompletedNCT00925730Phase 4
- A Study of a Probiotic in Atopic DermatitisCompletedNCT00893230Phase 3
- LEO 29102 Single and Multiple Dose Study by Dermal ApplicationCompletedNCT00891709Phase 1
- A Study of BRT-FC-83C for the Treatment of Atopic DermatitisCompletedNCT00883311Phase 2
- Safety and Efficacy of SRD441 Ointment in Patients With Atopic DermatitisCompletedNCT00882245Phase 2
- Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass IndexCompletedNCT00879944
- Vitamin D Supplementation in Childhood Atopic DermatitisCompletedNCT00879424Not applicable
- Investigation of Efficacy and Safety of EPOGAMCompletedNCT00878670Phase 4
- Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapyWithdrawnNCT00871208Phase 4
- Effect of Moisturising Creams on Skin Moisture in Atopic DermatitisCompletedNCT00846235Phase 4
- Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated PruritusCompletedNCT00838708Phase 2
- Phase IIa Study of WBI-1001 Cream for Atopic DermatitisCompletedNCT00837551Phase 1/2
- Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic DermatitisCompletedNCT00833079Phase 1
- Comparison of Video-Based Versus Written Patient Education on Atopic DermatitisCompletedNCT00826592Not applicable
- Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis PatientsCompletedNCT00822783Phase 4
- The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276
- IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic DermatitisCompletedNCT00820820Not applicable
- Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)CompletedNCT00817076Phase 3
- Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic DiseasesCompletedNCT00815984
- Study of Pimecrolimus Treatment for Atopic Dermatitis of African American ChildrenTerminatedNCT00810862Phase 4
- Study of Methotrexate Efficacy Versus Cyclosporine in Moderate to Severe Atopic Dermatitis PatientsCompletedNCT00809172Phase 3
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedNCT00801957Phase 2
- Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-upCompletedNCT00795496
- Effect of Moisturizing Creams on Skin Barrier FunctionStatus unknownNCT00771121Phase 4
- Dietetic Effects of Mare's Milk in Patients With Atopic DermatitisCompletedNCT00753805Not applicable
- A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)WithdrawnNCT00746382Phase 2
- A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 2 Doses of S-777469 in Patients With Atopic DermatitisCompletedNCT00703573Phase 2
- A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic DermatitisCompletedNCT00697710Phase 1/2
- Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep PhysiologyCompletedNCT00696397
- Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic DermatitisCompletedNCT00691366
- Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic DermatitisCompletedNCT00691262Phase 3
- Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic DermatitisCompletedNCT00691145Phase 3
- A Phase 2 Study of PH-10 for the Treatment of Atopic DermatitisCompletedNCT00690807Phase 2
- Protopic Ointment in Adult Atopic Eczema of the FaceCompletedNCT00690105Phase 4
- Protopic Ointment in Children Atopic EczemaCompletedNCT00689832Phase 4
- A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic EczemaCompletedNCT00676884Phase 2
- Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic DermatitisCompletedNCT00673725Phase 4
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic DermatitisCompletedNCT00667160Phase 4
- A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNCT00666302Phase 4
- Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic DermatitisCompletedNCT00666159Phase 4
- The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis PatientsCompletedNCT00660127
- Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic DermatitisCompletedNCT00616538Phase 4
- Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE LevelsCompletedNCT00616096Not applicable
- Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal RouteCompletedNCT00614731Phase 1
- Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic DermatitisCompletedNCT00610142Phase 2
- Safety and Efficacy Study of ImCOOH Cream in Patients Suffering From Moderate Atopic DermatitisTerminatedNCT00583895Phase 2
- Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a MoisturiserCompletedNCT00576238Phase 3
- 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used PimecrolimusActive, not recruitingNCT00568997
- A Clinical Study in Children and Adolescents With Mild to Moderate Atopic DermatitisCompletedNCT00568412Phase 4
- Long-term Safety of Protopic in Atopic EczemaCompletedNCT00560378Phase 3
- Tacrolimus Ointment Long Term Safety in Young Children With Atopic DermatitisCompletedNCT00560326Phase 2
- Montelukast as a Controller of Atopic SyndromeCompletedNCT00559546Phase 4
- Regulatory T Cells (Tregs) in Polymorphic Light EruptionCompletedNCT00555178
- The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic DermatitisCompletedNCT00550472Not applicable
- A Long-Term Examination of Asthma From Childhood Through AdolescenceCompletedNCT00541255
- Tacrolimus Ointment Pharmacokinetics in Infants With Atopic DermatitisCompletedNCT00535691Phase 2
- Distribution of Tacrolimus in Skin, Atopic DermatitisCompletedNCT00534508Phase 2
- Comparison of UVA1 Phototherapy Versus Photochemotherapy for Patients With Severe Generalized Atopic DermatitisCompletedNCT00533195Phase 3
- Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult PatientsCompletedNCT00523952Phase 3
- Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic DermatitisCompletedNCT00515047
- Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-oldCompletedNCT00510003Phase 4
- Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical SettingCompletedNCT00509990Phase 4
- A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic DermatitisCompletedNCT00484003Phase 4
- Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus OintmentCompletedNCT00480896Phase 3
- Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus OintmentCompletedNCT00480610Phase 3
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic DermatitisTerminatedNCT00475605
- Evaluation of Topical B12 for the Treatment of Childhood Atopic DermatitisStatus unknownNCT00465699Not applicable
- Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic DermatitisCompletedNCT00460083Phase 4
- Risk of Asthma in Infants With Atopic DermatitisCompletedNCT00459576
- Prednisolone vs. Ciclosporine in Severe Atopic EczemaCompletedNCT00445081Phase 4
- Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic DermatitisCompletedNCT00438022
- Medium-Dose UVA1 Versus Narrow-Band UVB in Atopic DermatitisCompletedNCT00419406Not applicable